Journal Basic Info
- Impact Factor: 1.995**
- H-Index: 8
- ISSN: 2474-1647
- DOI: 10.25107/2474-1647
Major Scope
- Surgical Oncology
- Gastroenterological Surgery
- Urology
- Pediatric Surgery
- Colon and Rectal Surgery
- Thoracic Surgery
- Otolaryngology - Head and Neck Surgery
- Minimally Invasive Surgery
Abstract
Citation: Clin Surg. 2022;7(1):3519.Case Report | Open Access
SARS Antibodies NCP, RBD and S2 in Women Vaccinated with Booster Pfizer Vaccine and Infected in Meantime with SARS-CoV-2
Małgorzata Polz-Dacewicz* and Agata Błaszczuk
Department of Virology, SARS Laboratory, Medical University of Lublin, Poland
*Correspondance to: Małgorzata Polz-Dacewicz
PDF Full Text DOI: 10.25107/2474-1647.3519
Abstract
The effective immunization plays a key role in preventing the spread of SARS-CoV-2 infection. The case study describes the serum titer of antibodies against NPC, RBD and S2 SARS-CoV-2 in 69-old women, who developed hybrid immunity. She was vaccinated with booster dose of Pfizer vaccine and was twice infected with SARS-CoV-2. Despite vaccination and booster dose, she was re-infected. Five months after the booster dose of the vaccine, serum levels of antibodies to RBD (806 U/mL) and S2 – (452 U/ml) were detected.
Keywords
Cite the article
Polz-Dacewicz M, Błaszczuk A. SARS Antibodies NCP, RBD and S2 in Women Vaccinated with Booster Pfizer Vaccine and Infected in Meantime with SARS-CoV-2. Clin Surg. 2022; 7: 3519..
